Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gengfu Xiao and Shufen Li.
Gengfu Xiao
Connection Strength
0.523
Shufen Li
  1. Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov. 2021 May 03; 7(1):29.
    View in: PubMed
    Score: 0.236
  2. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov. 2020 Dec 22; 6(1):96.
    View in: PubMed
    Score: 0.230
  3. High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2. ACS Infect Dis. 2021 06 11; 7(6):1409-1422.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.